HighTower Advisors’s ImmuCell ICCC Stock Holding History
Bought
Maintained
Sold
Other funds holding ICCC
CAM
BL
S
MFIM
HighTower Advisors's ICCC Position: Q2 2026 in Review
HighTower Advisors held its ImmuCell (ICCC) position steady in Q2 2026 at 24,354 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #3383.
HighTower Advisors first reported a position in ICCC in Q4 2019 and has held it in 27 quarters since. 31 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.
- HighTower Advisors held 24,354 shares of ImmuCell worth $245K as of Q2 2026.
- HighTower Advisors left its ImmuCell share count unchanged in Q2 2026.
- ImmuCell made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3383 holding.
- HighTower Advisors first reported a position in ImmuCell in Q4 2019 and has held it in 27 quarters since.
- 31 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.